Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
ABT Abbott Laboratories weekly Stock Chart
ABT [NYSE]
Abbott Laboratories
Healthcare | Medical Appliances & Equipment | USA
financial highlights | statements
IndexS&P 500 P/E58.88 EPS (ttm)1.49 Insider Own0.70% Shs Outstand1.76B Perf Week4.25%
Market Cap153.65B Forward P/E24.29 EPS next Y3.60 Insider Trans-14.54% Shs Float1.75B Perf Month3.75%
Income2.63B PEG5.06 EPS next Q0.80 Inst Own76.00% Short Float0.81% Perf Quarter18.36%
Sales30.72B P/S5.00 EPS this Y34.30% Inst Trans0.11% Short Ratio2.72 Perf Half Y24.06%
Book/sh17.54 P/B4.99 EPS next Y11.86% ROA3.80% Target Price87.00 Perf Year35.12%
Cash/sh1.86 P/C47.12 EPS next 5Y11.63% ROE8.50% 52W Range62.87 - 87.84 Perf YTD20.96%
Dividend1.28 P/FCF63.97 EPS past 5Y2.00% ROI6.10% 52W High-0.40% Beta1.11
Dividend %1.46% Quick Ratio1.10 Sales past 5Y9.20% Gross Margin58.40% 52W Low39.16% ATR1.33
Employees103000 Current Ratio1.60 Sales Q/Q2.00% Oper. Margin11.80% RSI (14)68.18 Volatility1.62% 1.31%
OptionableYes Debt/Eq0.62 EPS Q/Q39.20% Profit Margin8.50% Rel Volume1.11 Prev Close87.76
ShortableYes LT Debt/Eq0.61 EarningsJul 17 BMO Payout77.90% Avg Volume5.20M Price87.49
Recom1.90 SMA203.17% SMA508.23% SMA20016.41% Volume5,771,117 Change-0.31%
Jun-13-19Reiterated BofA/Merrill Buy $81 → $90
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Oct-19-17Reiterated RBC Capital Mkts Outperform $55 → $60
Oct-06-17Resumed JP Morgan Neutral
Sep-28-17Reiterated Barclays Overweight $57 → $60
Aug-17-17Initiated Citigroup Neutral $53
Jun-29-17Resumed Jefferies Buy
Jun-29-17Initiated Guggenheim Buy $58
Jun-21-17Resumed BTIG Research Buy $56
Jul-19-19 01:32PM  Top Research Reports for Abbott, Netflix & Philip Morris Zacks
10:41AM  Edited Transcript of ABT earnings conference call or presentation 17-Jul-19 1:00pm GMT Thomson Reuters StreetEvents
Jul-18-19 12:53PM  Calculating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT) Simply Wall St.
12:33PM  Abbott Labs Rises Following the Release of 2nd-Quarter Numbers GuruFocus.com
09:46AM  Company News for Jul 18, 2019 Zacks
09:19AM  IVD Market Sustains Momentum: 3 Stocks in Focus Zacks
09:00AM  Abbott (ABT) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks
Jul-17-19 06:23PM  Abbott Laboratories (ABT) Q2 2019 Earnings Call Transcript Motley Fool
05:37PM  Wall Street Lower on Wednesday GuruFocus.com
04:20PM  Abbott Stock Propelled Into Buy Zone As Medical Device Sales Fly Investor's Business Daily
04:19PM  US STOCKS-Wall St falls as CSX results signal damage from trade tensions Reuters
03:59PM  Abbott (ABT) Tops Q2 Earnings Estimates, Lifts EPS Guidance Zacks
03:41PM  5 Top Stock Trades for Thursday: TSLA, GLD, ABT InvestorPlace
03:12PM  US STOCKS-Wall St falls as CSX results point to damage from trade tensions Reuters
01:13PM  Abbott Laboratories Earnings: ABT Stock Surges on Guidance, Q2 Beat InvestorPlace
01:01PM  US STOCKS-Wall St falls as railroads slide after CSX signals trade impact Reuters
12:18PM  [video]Dow Ends Lower; S&P 500 Closes Below 3,000; CSX Tumbles TheStreet.com
12:03PM  US STOCKS-Wall St slips as railroads slide after CSX signals trade impact Reuters
11:15AM  Stocks edge lower after Dow snaps streak of record closes MarketWatch
11:14AM  Wall Street falls as CSX results signal damage from trade tensions Reuters
10:57AM  Trending Stocks For July 16: CTAS, ABT, BK, HSY; What's Up With Utilities? Investor's Business Daily
10:33AM  US STOCKS-Wall St flat as railroads slide after CSX signals trade impact Reuters
10:22AM  Mixed Housing Data for June Zacks
10:05AM  Housing Starts, Building Permits Mixed; Q2 for BAC, USB, ABT Zacks
09:33AM  Abbott hits record high as diabetes device fuels profit beat Reuters
09:14AM  Why these pricey growth stocks are worth keeping, says UBS MarketWatch
08:55AM  Abbott (ABT) Q2 Earnings Surpass Estimates Zacks
08:03AM  UPDATE 2-Diabetes devices power Abbott's profit beat, forecast raise Reuters
08:01AM  US-India Trade Tensions Rise: 3 Stocks in the Line of Fire Zacks
07:57AM  Abbott stock rises after earnings beat, full-year guidance boost MarketWatch
07:40AM  Abbott Labs quarterly profit jumps 37% Reuters
07:31AM  Abbott Reports Second-Quarter 2019 Results PR Newswire
07:00AM  Abbott Laboratories to Host Earnings Call ACCESSWIRE
06:16AM  Abbott Laboratories Hits Record High As FreeStyle Libre Sales Drive Q2 Earnings TheStreet.com
03:37AM  Abbott Labs Earnings Beat, Revenue Misses In Q2 Investing.com
Jul-16-19 11:34AM  5 Stocks with Spectacular Earnings Charts Zacks
07:45AM  Abbott MitraClip G4 Gets FDA Nod, Valve Repair Options Expand Zacks
06:34AM  Abbott to hike production of lower-cost glucose monitors as diabetes soars Reuters
06:00AM  FOCUS- Abbott to hike production of lower-cost glucose monitors as diabetes soars Reuters
Jul-15-19 12:46PM  Abbott Receives U.S. Approval of Next-Generation MitraClip®, Bringing New Enhancements to Abbott's Leading MitraClip Platform PR Newswire
10:26AM  Will Abbott's (ABT) Q2 Earnings Gain From Overall Growth? Zacks
09:12AM  ABT or BIO: Which Stock Has Better Potential Right Now? Zacks
06:00AM  Abbott Laboratories ABT- 2019 Top Picks' Mid-Year Update MoneyShow
Jul-13-19 06:00AM  The Week Ahead: Earnings Season Heats Up Morningstar
Jul-12-19 03:46PM  4 Healthcare Stocks That Are Feeling Sick InvestorPlace
06:15AM  Bull of the Day: Penumbra (PEN) Zacks
Jul-11-19 09:00AM  Abbott Announces FDA Approval of the Alinity s System, the Latest Technology for Screening and Protecting the U.S. Blood and Plasma Supply PR Newswire
Jul-10-19 01:16PM  The 10 Biggest Healthcare Stocks Motley Fool
10:30AM  Abbott (ABT) Earnings Expected to Grow: Should You Buy? Zacks
Jul-03-19 06:29AM  Analysts bullish on Boston Scientific's plans for 75 new products by 2022 American City Business Journals
Jul-02-19 07:56AM  Is Abbott Laboratories (NYSE:ABT) Investing Your Capital Efficiently? Simply Wall St.
Jun-29-19 05:57PM  How Citigroup and Other Hedge Fund Favorites Performed in Q2 Insider Monkey
Jun-27-19 05:50PM  Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Zacks
Jun-26-19 05:43PM  Abbott Ireland Financing DAC -- Moody's announces completion of a periodic review of ratings of Abbott Laboratories Moody's
Jun-25-19 11:09AM  Double Top Spells Trouble for 3 Health Care Stocks Investopedia
10:32AM  Abbvie Decides to Acquire Allergan Zacks
10:14AM  AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20 Zacks
10:08AM  Most Important Mergers and Acquisitions of 2016 Investopedia
09:10AM  Allergan Is a $63 Billion Botox Job for AbbVie Bloomberg
12:00AM  Smith & Nephew directors discussed US listing to boost CEO pay Financial Times
Jun-24-19 09:00AM  Nutrition Is the Missing Ingredient in Home Health Today, New Study Shows PR Newswire
Jun-19-19 09:00AM  Abbott Hosts Conference Call for Second-Quarter Earnings PR Newswire
08:00AM  Is Abbott Laboratories a Buy? Motley Fool
Jun-18-19 05:50PM  Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Zacks
Jun-17-19 12:00PM  CARE, Abbott and the Abbott Fund Launch Partnership to Address Noncommunicable Diseases (NCDs) in Humanitarian Settings PR Newswire
08:00AM  Abbott Launches First-ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes PR Newswire
07:40AM  Abbott (ABT) Hits New 52-Week High on Solid Growth Drivers Zacks
Jun-14-19 10:45AM  Abbott Declares 382 Consecutive Quarterly Dividend PR Newswire
Jun-13-19 09:00AM  Abbott (ABT) Moves to Buy: Rationale Behind the Upgrade Zacks
09:00AM  New Survey Shows Millennials Can Help Avoid Blood Shortages PR Newswire
Jun-12-19 08:28AM  Traders Look to Buy Global Health Care Stocks Investopedia
Jun-10-19 05:45PM  Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Zacks
04:40PM  Heres What Hedge Funds Think About Abbott Laboratories (ABT) Insider Monkey
09:38AM  The Zacks Analyst Blog Highlights: Mastercard, Disney, Abbott, Workday and Sun Life Zacks
Jun-09-19 07:00AM  Where Will Abbott Laboratories Be in 10 Years? Motley Fool
Jun-08-19 01:00PM  CORRECTED-Abbott device helps in cutting blood sugar in type 2 diabetics - study (June 8) Reuters
01:00PM  New Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes PR Newswire
Jun-07-19 01:09PM  Top Research Reports for Mastercard, Disney & Abbott Zacks
Jun-06-19 09:30AM  Is Abbott Laboratories (ABT) Outperforming Other Medical Stocks This Year? Zacks
Jun-04-19 05:45PM  Abbott (ABT) Gains But Lags Market: What You Should Know Zacks
11:47AM  Abbott (ABT) Grows on EPD Amid Rhythm Management Challenges Zacks
Jun-03-19 02:15PM  Did Abbott Laboratories (NYSE:ABT) Use Debt To Deliver Its ROE Of 8.3%? Simply Wall St.
Jun-01-19 09:08PM  Here is the 18th Most Popular Stock Among Hedge Funds Insider Monkey
May-29-19 05:50PM  Abbott (ABT) Stock Moves -0.05%: What You Should Know Zacks
09:31AM  The Top Health Care Companies in the World Investopedia
May-24-19 01:44PM  The highest-paid CEOs by state Associated Press
12:21PM  One sector is making a comeback amid market volatility CNBC
May-23-19 05:45PM  Abbott (ABT) Dips More Than Broader Markets: What You Should Know Zacks
May-22-19 11:27AM  3 Dividend Aristocrats to Buy and Hold Forever Motley Fool
May-21-19 10:45AM  TRILUMINATE Study Shows Treatment with Abbott's First-of-its-Kind Minimally Invasive Device Reduces Tricuspid Heart Valve Leaks PR Newswire
May-18-19 10:25AM  Should Abbott Laboratories (NYSE:ABT) Be Part Of Your Dividend Portfolio? Simply Wall St.
May-17-19 09:30AM  Why Is Abbott (ABT) Up 3.6% Since Last Earnings Report? Zacks
May-16-19 08:00AM  New ZonePerfect® Keto is 100% #TrueKeto with the Proven Blend of Macros for Effective Results PR Newswire
May-15-19 07:18AM  Nearly 9 out of 10 College Students with Student Debt Say It's Important to Find a Company That Offers Loan Relief PR Newswire
05:34AM  Bull of the Day: Penumbra (PEN) Zacks
May-14-19 10:07AM  Here are the stocks to buy if an all-out U.S.-China trade war erupts, says Goldman MarketWatch
09:00AM  Abbott Partners With NIH On BRAIN Initiative to Advance Research for Neurological Disorders PR Newswire
May-13-19 02:06PM  Is Pinterest a compelling buy? Is Abbott heading to new highs? The desk answers viewer questions CNBC Videos
10:37AM  Abbott Rides on Strong CGM, Poor Rhythm Management Ails Zacks
May-10-19 09:00AM  Abbott (ABT) Upgraded to Buy: What Does It Mean for the Stock? Zacks
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. Its Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems for infectious diseases; molecular point-of-care care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company also provides glucose and blood glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Salvadori Daniel Gesua SiveExecutive Vice PresidentJun 26Option Exercise38.4071,0002,726,400167,148Jun 27 05:01 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentJun 26Sale84.0071,0005,964,00796,148Jun 27 05:01 PM
Wainer Andrea FExecutive Vice PresidentJun 21Sale85.131,188101,13441,260Jun 24 05:59 PM
ALLEN HUBERT LExecutive Vice PresidentJun 20Option Exercise34.94165,0005,765,100311,010Jun 21 05:19 PM
CAPEK JOHN MExecutive Vice PresidentJun 20Option Exercise26.1946,9001,228,213355,435Jun 21 05:20 PM
ALLEN HUBERT LExecutive Vice PresidentJun 20Sale85.00165,00014,025,000146,010Jun 21 05:19 PM
CAPEK JOHN MExecutive Vice PresidentJun 20Sale85.0046,9003,986,500308,535Jun 21 05:20 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentJun 13Sale82.003,331273,14296,148Jun 13 05:12 PM
LANE ANDREW HExecutive Vice PresidentJun 12Option Exercise48.9073,4243,590,434119,362Jun 14 05:03 PM
LANE ANDREW HExecutive Vice PresidentJun 12Sale81.4273,4245,978,19745,938Jun 14 05:03 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentJun 11Sale82.007,269596,05899,479Jun 13 05:12 PM
Blaser Brian JExecutive Vice PresidentMay 23Option Exercise38.43450,06217,294,801580,807May 24 05:02 PM
Blaser Brian JExecutive Vice PresidentMay 23Sale75.52450,06233,988,727130,745May 24 05:02 PM
Watkin JaredSenior Vice PresidentMay 02Option Exercise46.18309,42914,290,631383,964May 06 05:04 PM
Watkin JaredSenior Vice PresidentMay 02Sale78.51309,42924,294,19974,535May 06 05:04 PM
Contreras JaimeSenior Vice PresidentApr 26Option Exercise38.4080,8603,105,024115,566Apr 29 05:35 PM
Contreras JaimeSenior Vice PresidentApr 25Option Exercise51.3082,7324,243,867117,438Apr 29 05:35 PM
Contreras JaimeSenior Vice PresidentApr 25Sale70.0082,7325,791,48734,706Apr 29 05:35 PM
Fussell Stephen RExecutive Vice PresidentApr 23Option Exercise47.0056,0002,632,000225,935Apr 24 05:10 PM
Fussell Stephen RExecutive Vice PresidentApr 23Sale76.0056,0004,256,000169,935Apr 24 05:10 PM
WOODGRIFT RANDEL WILLIAMSenior Vice PresidentApr 22Buy73.402,000146,79852,562Apr 24 05:05 PM
Contreras JaimeSenior Vice PresidentApr 22Sale73.1291867,1242,227Apr 24 05:06 PM
MANNING JOSEPH JSenior Vice PresidentMar 20Sale79.585,613446,66550,529Mar 21 05:10 PM
WHITE MILES DChairman and CEOMar 18Option Exercise24.29589,70014,324,3233,763,865Mar 20 05:29 PM
WHITE MILES DChairman and CEOMar 18Sale78.5576,0695,974,9893,174,165Mar 20 05:33 PM
WHITE MILES DChairman and CEOMar 18Sale78.5281,5806,405,7813,326,190Mar 20 05:31 PM
WHITE MILES DChairman and CEOMar 18Sale78.5775,9565,967,8373,250,234Mar 20 05:31 PM
WHITE MILES DChairman and CEOMar 18Sale78.6274,2225,835,4013,613,904Mar 20 05:29 PM
WHITE MILES DChairman and CEOMar 18Sale78.5176,7196,023,1533,537,185Mar 20 05:30 PM
WHITE MILES DChairman and CEOMar 18Sale78.65128,31510,092,3573,408,870Mar 20 05:31 PM
WHITE MILES DChairman and CEOMar 18Sale78.6175,7395,953,9543,688,126Mar 20 05:29 PM
BIRD ROGERSenior Vice PresidentMar 13Sale79.069,188726,41659,807Mar 14 05:01 PM
Bracken Sharon JSenior Vice PresidentMar 06Sale77.835,500428,07444,919Mar 08 05:07 PM
YOOR BRIAN BExecutive Vice President & CFOMar 01Sale78.002,246175,188114,381Mar 04 05:35 PM
Watkin JaredSenior Vice PresidentMar 01Sale78.001,391108,49874,535Mar 04 05:33 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 01Sale78.001,664129,792106,748Mar 04 05:32 PM
MANNING JOSEPH JSenior Vice PresidentMar 01Sale78.001,22395,39456,142Mar 04 05:30 PM
Fussell Stephen RExecutive Vice PresidentMar 01Sale78.002,246175,188169,935Mar 04 05:26 PM
Funck Robert ESenior Vice PresidentMar 01Sale78.001,00278,156138,991Mar 04 05:24 PM
Contreras JaimeSenior Vice PresidentMar 01Sale78.2812,561983,286103,446Mar 04 05:23 PM
Blaser Brian JExecutive Vice PresidentMar 01Sale78.2316,1551,263,737130,745Mar 04 05:18 PM
Bracken Sharon JSenior Vice PresidentMar 01Sale78.001,22495,47250,419Mar 04 05:19 PM
BRYNELSEN CHARLESSenior Vice PresidentMar 01Sale78.001,00278,15641,111Mar 04 05:21 PM
ALLEN HUBERT LExecutive Vice PresidentMar 01Sale78.002,246175,188146,010Mar 04 05:17 PM
BIRD ROGERSenior Vice PresidentMar 01Sale78.001,11386,81468,995Mar 04 05:18 PM
Contreras JaimeSenior Vice PresidentJan 31Option Exercise42.24140,1505,920,120231,798Feb 01 05:44 PM
Stratton John GDirectorJan 31Buy72.323,455249,8756,400Feb 01 05:43 PM
Contreras JaimeSenior Vice PresidentJan 30Option Exercise43.06214,1379,220,941269,105Feb 01 05:44 PM
Contreras JaimeSenior Vice PresidentJan 30Sale70.00177,45712,421,99091,648Feb 01 05:44 PM
WHITE MILES DChairman and CEONov 28Option Exercise26.02325,0008,454,8753,459,185Nov 30 05:02 PM
WHITE MILES DChairman and CEONov 28Sale72.49177,14012,840,5983,139,704Nov 30 05:03 PM
WHITE MILES DChairman and CEONov 28Sale72.585,519400,5823,134,185Nov 30 05:03 PM
WHITE MILES DChairman and CEONov 28Sale72.35142,34110,298,6103,316,844Nov 30 05:02 PM
Watkin JaredSenior Vice PresidentNov 02Option Exercise38.4065,0002,496,000128,640Nov 06 05:08 PM
Watkin JaredSenior Vice PresidentNov 02Sale71.0065,0004,615,00063,640Nov 06 05:08 PM
Bracken Sharon JSenior Vice PresidentSep 28Sale73.351,732127,04439,029Oct 02 06:58 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentSep 28Sale73.395,000366,95788,521Oct 02 06:58 PM
Blaser Brian JExecutive Vice PresidentSep 20Option Exercise27.4358,2001,596,165195,018Sep 21 05:02 PM
Blaser Brian JExecutive Vice PresidentSep 20Sale68.7958,2004,003,862136,818Sep 21 05:02 PM
Funck Robert ESenior Vice PresidentSep 05Option Exercise25.2436,400918,727145,080Sep 07 05:15 PM
Contreras JaimeSenior Vice PresidentAug 29Option Exercise37.67172,4686,496,984222,904Aug 31 05:04 PM
Contreras JaimeSenior Vice PresidentAug 29Sale66.8464,2684,295,39554,968Aug 31 05:05 PM
Contreras JaimeSenior Vice PresidentAug 29Sale66.7495,7936,393,590127,111Aug 31 05:04 PM
LANE ANDREW HExecutive Vice PresidentAug 29Sale67.119,097610,51326,583Aug 31 05:03 PM
Bracken Sharon JSenior Vice PresidentJul 30Sale65.1661540,07340,761Jul 31 05:01 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Option Exercise26.0264,9001,688,374363,200Jul 26 05:05 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Sale65.0064,9004,218,500298,300Jul 26 05:05 PM
Blaser Brian JExecutive Vice PresidentJul 24Sale63.9615,100965,789136,818Jul 26 05:09 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 24Sale63.5080350,99178,417Jul 24 05:02 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 23Sale63.2024715,61079,220Jul 24 05:02 PM
Bracken Sharon JSenior Vice PresidentJul 23Sale63.2025916,36941,376Jul 24 05:01 PM
open in yahoo | open in reuters | open in google